{"filing":{"accession_number":"0001104659-26-105912","cik":"0001725255","ticker":"AHCO","company_name":"AdaptHealth Corp.","form":"8-K","filing_date":"2026-09-08","report_date":"2026-09-03","primary_document":"tm2624956d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1725255/000110465926105912/tm2624956d1_8k.htm"},"events":[{"id":31990,"run_id":29385,"accession_number":"0001104659-26-105912","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.93,"summary":"AdaptHealth appointed Harriss Currie as Chief Financial Officer effective September 9, 2026, with a base salary of $670,000, 100% target bonus, and $818,462 in RSUs. The appointment replaces Jason Clemens' departure as CFO and represents a material change in the company's financial leadership.","company_name":"AdaptHealth Corp.","ticker":"AHCO","filing_date":"2026-09-08","form":"8-K","submitted_at":null,"items":[{"id":35046,"accession_number":"0001104659-26-105912","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of Harriss Currie as Chief Financial Officer effective September 9, 2026, with detailed employment terms including $670,000 base salary, 100% target bonus, and $818,462 in RSUs. While the filing also mentions Jason Clemens' departure as CFO, the principal disclosed action centers on the appointment of a new CFO with comprehensive compensation arrangements, making exec_appointment the most salient classification. The appointment of a CFO is material to investors as it affects the company's financial leadership and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T20:18:28.820565+00:00","company_name":"","ticker":null,"filing_date":""},{"id":35047,"accession_number":"0001104659-26-105912","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Harriss T. Currie as Chief Financial Officer of AdaptHealth, effective September 9, 2026. Although Item 7.01 furnishes a press release, the core event is the executive appointment referenced in Item 5.02 above. The CFO is a named executive officer position material to investors' assessment of company leadership and financial stewardship.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T20:18:28.820565+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35046,"accession_number":"0001104659-26-105912","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses the appointment of Harriss Currie as Chief Financial Officer effective September 9, 2026, with detailed employment terms including $670,000 base salary, 100% target bonus, and $818,462 in RSUs. While the filing also mentions Jason Clemens' departure as CFO, the principal disclosed action centers on the appointment of a new CFO with comprehensive compensation arrangements, making exec_appointment the most salient classification. The appointment of a CFO is material to investors as it affects the company's financial leadership and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T20:18:28.820565+00:00","company_name":"AdaptHealth Corp.","ticker":"AHCO","filing_date":"2026-09-08"},{"id":35047,"accession_number":"0001104659-26-105912","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the appointment of Harriss T. Currie as Chief Financial Officer of AdaptHealth, effective September 9, 2026. Although Item 7.01 furnishes a press release, the core event is the executive appointment referenced in Item 5.02 above. The CFO is a named executive officer position material to investors' assessment of company leadership and financial stewardship.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-08T20:18:28.820565+00:00","company_name":"AdaptHealth Corp.","ticker":"AHCO","filing_date":"2026-09-08"}]}